Millennium Nutrient N,N-Dimethylglycine (DMG) and its Effectiveness in Autism Spectrum Disorders.
Dimethylglycine
autism spectrum disorders (ASD)
central nervous system (CNS)
complementary and alternative medicine (CAM)
neurological disorders
pharmacology
Journal
Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
04
2021
revised:
09
10
2021
accepted:
11
10
2021
pubmed:
27
11
2021
medline:
24
5
2022
entrez:
26
11
2021
Statut:
ppublish
Résumé
Autism is a neurodevelopmental disorder belonging to the autism spectrum disorder (ASD). In ASDs, the individuals show substantial impairments in social communication, repetitive behaviours, and sensory behaviours deficits in the early stages of their life. Globally, the prevalence of autism is estimated to be less than 1%, especially in high- -income countries. In recent decades, there has been a drastic increase in the incidence of ASD, which has put ASD into the category of epidemics. Presently, two US Food and Drug Administration-approved drugs, aripiprazole and risperidone, are used to treat symptoms of agitation and irritability in autistic children. However, to date, no medication has been found to treat the core symptoms of ASD. The adverse side effects of conventional medicine and limited treatment options have led families of autistic children to turn to complementary and alternative medicine (CAM) treatments, which are perceived as relatively safe compared to conventional medicine. Recently N, N-dimethylglycine (DMG), a dietary supplement, has emerged as a useful supplement to improve the mental and physical state of children with ASD. The current review discusses ASD, the prevalence of ASD, the CAM approach, and the efficacy of CAM treatment in children with ASD. Moreover, it highlights the chemistry, pharmacological effect, and clinical studies of DMG, highlighting its potential for improving the lifestyle of children with ASD.
Identifiants
pubmed: 34823458
pii: CMC-EPUB-119050
doi: 10.2174/0929867328666211125091811
doi:
Substances chimiques
dimethylglycine
7797M4CPPA
Sarcosine
Z711V88R5F
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2632-2651Subventions
Organisme : University Hospital Hradec Kralove, UHK PrF project
ID : VT2019-2021
Organisme : PERSONMED—Center for the Development of Personalized Medicine in Age-Related Diseases
ID : CZ.02.1.01/0.0/0.0/17_048/0007441
Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.